Wěi Li
Beijing Tongren Hospital · 1,954 works · 64,744 citations · h-index 106
Top works
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
- Afatinib versus cisplatin plus gemcitabine for first-line treatment of Asian patients with advanced non-small-cell lung cancer harbouring EGFR mutations (LUX-Lung 6): an open-label, randomised phase 3 trial
- Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
- HIF-1α pathway: role, regulation and intervention for cancer therapy
- Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
- Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II–IIIA (N1–N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study
- Role of dimerization and modification of the CSF‐1 receptor in its activation and internalization during the CSF‐1 response.
- Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial
- An Overview of Tubulin Inhibitors That Interact with the Colchicine Binding Site
- A NewMycobacteriumSpecies Causing Diffuse Lepromatous Leprosy
- Afatinib versus erlotinib as second-line treatment of patients with advanced squamous cell carcinoma of the lung (LUX-Lung 8): an open-label randomised controlled phase 3 trial
- Interleukin-6 Protects against Fas-mediated Death by Establishing a Critical Level of Anti-apoptotic Hepatic Proteins FLIP, Bcl-2, and Bcl-xL
- In vivo measurement of water diffusion in the human heart
- Integrative analysis of HIF binding and transactivation reveals its role in maintaining histone methylation homeostasis
- Tyrosine phosphorylation of a common 57-kDa protein in growth factor-stimulated and -transformed cells.
- Overcoming Therapeutic Resistance in HER2-Positive Breast Cancers with CDK4/6 Inhibitors
- Properties of chicken erythrocyte histone deacetylase associated with the nuclear matrix
- Oxysterols direct immune cell migration via EBI2
- The BACE1 inhibitor verubecestat (MK-8931) reduces CNS β-amyloid in animal models and in Alzheimer’s disease patients
- Pyrotinib plus capecitabine versus lapatinib plus capecitabine for the treatment of HER2-positive metastatic breast cancer (PHOEBE): a multicentre, open-label, randomised, controlled, phase 3 trial